Submitted by Anonymous (not verified) on 30 September 2026 - 7:31
Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 40, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 40, Status: Authorised